Home › Funds › Palo Alto Investors LP › CDNA
Palo Alto Investors LP position in CDNA
CAREDX INC · Health Care
Palo Alto Investors LP reported holding 424,601 shares of CDNA (CAREDX INC) in its Q3 2026 13F filing — a position valued at US$27.6M, representing 4.11% of its reported portfolio and ranking #11 among its reported holdings. Palo Alto Investors LP has disclosed CDNA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's CDNA position evolved
Palo Alto Investors LP first disclosed a stake in CDNA in Q3 2025 at 316,204 shares (US$4.6M). The position peaked in Q3 2026 at 424,601 shares, worth US$27.6M. Across 5 filings, Palo Alto Investors LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 424,601 shares valued at US$27.6M — a reduction of -107,269 shares quarter over quarter.. Notable position changes include a 51% increase in Q4 2025 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 316.20K | $4.60M | New |
| Q4 2025 | 478.22K | $9.01M | Add |
| Q1 2026 | 531.87K | $9.23M | Add |
| Q2 2026 | 531.87K | $15.16M | Hold |
| Q3 2026 | 424.60K | $27.60M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDNA and 13F data
CDNA (CAREDX INC) is a Health Care company. 51 other funds we track also report a position in CDNA — the largest reported positions include Blue Water Life Science Advisors, LP (US$113.1M), ARK Invest (US$104.6M), Divisadero Street Capital Management, LP (US$92.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDNA
- Blue Water Life Science Advisors, LP 1.74M sh · $113.10M · Q3 2026
- ARK Invest 1.61M sh · $104.59M · Q3 2026
- Divisadero Street Capital Management, LP 1.42M sh · $92.31M · Q3 2026
- GAGNON SECURITIES LLC 1.07M sh · $69.84M · Q3 2026
- ORBIMED ADVISORS LLC 934.80K sh · $60.76M · Q3 2026
- Amova Asset Management Americas, Inc. 625.42K sh · $40.63M · Q3 2026
- Ophir Asset Management Pty Ltd 582.41K sh · $37.86M · Q3 2026
- Portolan Capital Management, LLC 420.21K sh · $27.31M · Q3 2026
- Zweig-DiMenna Associates LLC 389.81K sh · $25.34M · Q3 2026
- Gagnon Advisors, LLC 286.89K sh · $18.65M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held CDNA?
Palo Alto Investors LP has disclosed CDNA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Palo Alto Investors LP's current position in CDNA?
As of Q3 2026, Palo Alto Investors LP holds 424.60K shares of CDNA (CAREDX INC), valued at $27.60M, representing 4.11% of its reported portfolio and ranking #11.
Has Palo Alto Investors LP been buying or selling CDNA?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in CDNA. The position peaked in Q3 2026 at 424.60K shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include Blue Water Life Science Advisors, LP, ARK Invest, Divisadero Street Capital Management, LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.